Clinical trials
Phase 3 Sleep Apnea, Obstructive trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Not yet recruiting | 4 |
| Completed | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Gan & Lee Pharmaceuticals. | 2 |
| Hangzhou Sciwind Biosciences Co., Ltd. | 2 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2 |
| Novo Nordisk A/S | 2 |
| Adelaide Institute for Sleep Health | 1 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 1 |
| Ignis Therapeutics (Suzhou) Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Apnea, Obstructive | 13 |
| Obesity | 10 |
| Overweight | 3 |
| Cardiovascular Diseases | 1 |
| Disorders of Excessive Somnolence | 1 |
| Sleep Apnea Syndromes | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.